Who is most at risk of dying if infected with SARS-CoV-2? A mortality risk factor analysis using machine learning of patients with COVID-19 over time: a large population-based cohort study in Mexico.

Who is most at risk of dying if infected with SARS-CoV-2? A mortality risk factor analysis using machine learning of patients with COVID-19 over time: a large population-based cohort study in Mexico.

Publication date: Sep 22, 2023

COVID-19 would kill fewer people if health programmes can predict who is at higher risk of mortality because resources can be targeted to protect those people from infection. We predict mortality in a very large population in Mexico with machine learning using demographic variables and pre-existing conditions. Cohort study. March 2020 to November 2021 in Mexico, nationally represented. 1. 4 million laboratory-confirmed patients with COVID-19 in Mexico at or over 20 years of age. Analysis is performed on data from March 2020 to November 2021 and over three phases: (1) from March to October in 2020, (2) from November 2020 to March 2021 and (3) from April to November 2021. We predict mortality using an ensemble machine learning method, super learner, and independently estimate the adjusted mortality relative risk of each pre-existing condition using targeted maximum likelihood estimation. Super learner fit has a high predictive performance (C-statistic: 0. 907), where age is the most predictive factor for mortality. After adjusting for demographic factors, renal disease, hypertension, diabetes and obesity are the most impactful pre-existing conditions. Phase analysis shows that the adjusted mortality risk decreased over time while relative risk increased for each pre-existing condition. While age is the most important predictor of mortality, younger individuals with hypertension, diabetes and obesity are at comparable mortality risk as individuals who are 20 years older without any of the three conditions. Our model can be continuously updated to identify individuals who should most be protected against infection as the pandemic evolves.

Open Access PDF

Concepts Keywords
Diabetes COVID-19
Dying epidemiology
Learning general diabetes
Mexico hypertension
October risk factors
statistics & research methods

Semantics

Type Source Name
disease MESH COVID-19
disease VO time
disease VO population
disease MESH infection
disease MESH hypertension
disease MESH obesity
disease MESH death
disease IDO country
drug DRUGBANK Coenzyme M
disease MESH chronic kidney disease
disease MESH chronic renal failure
disease MESH congestive heart failure
disease MESH kidney disease
disease MESH liver disease
disease MESH cardiovascular disease
disease MESH dementia
disease MESH COPD
disease MESH pneumonia
disease MESH cancer
disease MESH mental illness
disease VO organ
disease IDO algorithm
disease IDO facility
disease IDO process
disease MESH asthma
pathway KEGG Asthma
disease MESH haemolytic anaemia
disease MESH renal tuberculosis
drug DRUGBANK Flunarizine
disease VO efficient
disease VO age
disease MESH comorbidity
disease MESH uncertainty
disease IDO susceptibility
disease VO vaccination
disease VO USA
drug DRUGBANK Etoperidone
pathway REACTOME Translation
disease MESH Infectious Diseases
disease MESH AIDS
disease MESH Non communicable diseases
disease MESH Chronic diseases
disease MESH Overweight
drug DRUGBANK Saquinavir

Original Article

(Visited 1 times, 1 visits today)